About Eaglenos
Eaglenos is a company based in Nanjing (China) founded in 2017. Eaglenos has raised $21.2 million across 1 funding round from investors including 3E Bioventures, Huatai Zijin Investment and Innomed Capital. Eaglenos offers products and services including Test Paper Platform and Test Card Platform.
- Headquarter Nanjing, China
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website eaglenos.com
- Social LinkedIn Facebook
- Legal Name 南京晶捷生物科技有限公司
- Date of Incorporation 10 Aug, 1977
- Jurisdiction Maharashtra, India
- Total Equity Funding$21.2M (USD)
in 1 rounds
- Latest Funding Round$21.2M (USD), Series A
May 2023
- Investors3E Bioventures
& 3 more
Associated legal entities of Eaglenos
Eaglenos operates through , (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| , CIN U99999MH1977PLC010754 | Active | 10 Aug 1977 | Nanded, Maharashtra | – | – | – | View details |
Products & Services of Eaglenos
Eaglenos offers a comprehensive portfolio of products and services, including Test Paper Platform and Test Card Platform.
Test paper platforms are used for precise detection in health management applications
Test card platforms are employed for point-of-care testing to support personalized health solutions
Funding Insights of Eaglenos
Eaglenos has successfully raised a total of $21.2M through 1 strategic funding round. The most recent funding activity was a Series A round of $21.2 million completed in May 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $21.2M
- Total Rounds 1
- Last Round Series A β $21.2M
- First Round $21.2M
(May 2023)
- Investors Count 4
All 1 funding rounds of Eaglenos with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2023 | $21.2M | Series A | β | 3E BioVentures |
4 investors in total: 4 institutional.
Investors in Eaglenos
Eaglenos has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include 3E Bioventures, Huatai Zijin Investment and Innomed Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A fund focused on healthcare industry investments is managed. | 2015 | 3ebiovc.cn | China | |
Innomed Capital is engaged in equity investment fund management. | 2018 | innomed-capital.com | Nanjing, China | |
Private equity investments are managed by the company. | 2012 | grandyangtze.com | Shanghai, China | |
Manages diversified investment portfolios across various asset classes. | 1991 | htzjtz.com.cn | Nanjing, China |
Investor details for Eaglenos
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Eaglenos
2 dated milestones of Eaglenos across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Eaglenos is founded.
- Funding First funding round of $21.2M.
Web traffic of Eaglenos
The website of Eaglenos (eaglenos.com) receives about 3.2K visits a month.
- Monthly visits3.2K
▲ 134.7% vs previous month
Similar companies to Eaglenos
10 companies that operate in the same segment as Eaglenos (Traditional Diagnostics & Medical Devices), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Materials management solutions are provided for healthcare organizations. | 1892 | Chicago, Illinois, United States | USD 29.13 M | USD 20.63 B | 53,000 | |
3D-printed orthopedic products are manufactured for medical applications. | 1941 | Kalamazoo, Michigan, United States | – | – | – | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | – | USD 5.1 B | 13,500 | |
Heart pumps are developed for blood circulation and oxygenation support. | 1981 | Danvers, Massachusetts, United States | – | USD 1.03 B | 1,157 | |
Medical device management services are provided to healthcare facilities. | 1999 | Exeter, New Hampshire, United States | USD 275.93 M | USD 68.67 M | 353 | |
Medical surgical consumables including sutures and anti-microbial gloves are manufactured. | 1992 | Bengaluru, Karnataka, India | USD 102.36 M | USD 7.14 K | 39 | |
Manufacturer of medical equipments | 1967 | Bengaluru, Karnataka, India | USD 58.9 M | USD 98.65 M | 578 | |
BD is recognized for providing innovative medical technology solutions. | 1897 | Franklin Lakes, New Jersey, United States | – | USD 21.84 B | 74,000 | |
Dental lasers and scanning devices are developed for clinical use. | 1987 | Foothill Ranch, California, United States | – | USD 49.16 M | – | |
Manufacturer and distributor of aprons, surgical gowns, uniforms, and other medical products | 1966 | Mundelein, Illinois, United States | – | USD 28.45 B | 1,305 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Eaglenos
Eaglenos was founded in 2017 and raised its 1st funding round 6 years after it was founded.
Eaglenos is headquartered in Nanjing, China. It is registered at Nanjing, Jiangsu, China.
Eaglenos is a funded company, having raised a total of $21.2M across 1 funding round to date. The company's 1st funding round was a Series A of $21.2M, raised on May 2023.
Eaglenos was established in 2017 in Nanjing, China, within the medical diagnostics sector. Diagnostic test kits are produced by the company to support healthcare testing needs. Operations are conducted from its base in Nanjing, where manufacturing processes are managed. The companys online presence is maintained through eaglenos.com, facilitating access to product information and distribution channels. Focus is placed on developing kits for various diagnostic purposes, serving regional and international markets.
Eaglenos offers Test Paper Platform and Test Card Platform.
Eaglenos has 4 investors. Key investors include 3E Bioventures, Huatai Zijin Investment, Innomed Capital, and Grand Yangtze.
Eaglenos operates through ,.